News
Filter
-
New AI tool aims to detect early signs of dementia during routine eye tests
-
LifeArc and Cleveland Clinic join forces to develop new monoclonal antibody therapeutics for patients with high unmet medical needs
-
Third global Longitude Prize to be launched in 2025 focusing on ALS
-
LifeArc appoints Chief Medical Officer to deliver more scientific breakthroughs for patients
-
Clare Terlouw, Head of LifeArc Ventures, talks to In Vivo’s Ashley Yeo on the improving investment climate
-
£2.7m infectious disease fund to boost rapid testing, drug trials and innovative specimen storage
-
LifeArc Ventures invests in Fluid Biomed
-
Promising results in clinical trial gives hope to patients with blood disorder
-
3 steps LifeArc is taking to tackle antimicrobial resistance before it’s too late
-
£76M investment backing into potential MND treatment, underlines benefit of charity funding
-
Tackling antimicrobial resistance: LifeArc partners with the University of Cape Town to launch a new Centre for Translational AMR Research
-
LifeArc joins public involvement pledge to improve health research
